Can Targeting Glutaminase be a Therapeutic Strategy?
Yes, targeting glutaminase has emerged as a promising therapeutic strategy in cancer treatment. By inhibiting glutaminase, it is possible to disrupt the metabolic flexibility of cancer cells, leading to reduced proliferation and increased apoptosis. Several glutaminase inhibitors are currently under investigation in preclinical and clinical studies.
